Literature DB >> 8098728

[A new histologic diagnosis for amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes mucin-type glycoprotein].

H Ohi1, H Kobayashi, T Terao.   

Abstract

Sialyl Tn structure (NeuAc alpha 2-6 GalNAc 1-0-Ser/Thr) recognized by monoclonal antibody TKH-2 is a characteristic component in meconium- and/or amniotic fluid-derived mucin. The purpose of this study was to evaluate whether immunohistochemical staining employing antibody TKH-2 is a sensitive method for histological diagnosis of amniotic fluid embolism (AFE). The intravenous injection of 10% meconium solution (1 ml/kg) into rabbits was carried out. Formalin-fixed, paraffin-embedded lung, liver, and kidney tissue sections were obtained at various time interval after injections. Specimens were stained by the Streptavidin Biotin Complex method. The results of immunostaining were compared to those of hematoxylin and eosin (H & E) stain or a conventional Alcian blue stain. Remarkable positive stainings were easily seen within the pulmonary artery vasculature in experimental rabbits. Meconium-derived mucin can be easily missed on H & E sections. Compared to TKH-2 staining, Alcian blue staining may also be insufficient to demonstrate intravascular mucin in the lung sections. TKH-2 staining is the most sensitive method to use in detecting meconium-derived mucin in the lung sections of rabbits with an AFE experimental model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098728

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  2 in total

1.  Immunohistochemical identification of syncytiotrophoblastic cells and megakaryocytes in pulmonary vessels in a fatal case of amniotic fluid embolism.

Authors:  P Lunetta; A Penttilä
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

2.  Amniotic fluid embolism with involvement of the brain, lungs, adrenal glands, and heart.

Authors:  J Balazic; T Rott; T Jancigaj; M Popović; M Zajfert-Slabe; V Svigelj
Journal:  Int J Legal Med       Date:  2003-05-06       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.